Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$3.08 - $5.02 $15,400 - $25,099
5,000 Added 80.98%
11,174 $34,000
Q4 2023

Feb 09, 2024

BUY
$2.85 - $4.19 $17,595 - $25,869
6,174 New
6,174 $23,000
Q4 2022

Feb 13, 2023

BUY
$3.78 - $5.81 $2,547 - $3,915
674 New
674 $2,000
Q3 2021

Nov 05, 2021

SELL
$3.57 - $5.6 $1,428 - $2,240
-400 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$3.46 - $4.92 $1,384 - $1,968
400 New
400 $2,000
Q1 2021

May 24, 2021

SELL
$3.27 - $7.14 $1,308 - $2,856
-400 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$1.79 - $3.3 $716 - $1,320
400 New
400 $1,000

Others Institutions Holding ANIX

About Anixa Biosciences Inc


  • Ticker ANIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,661,700
  • Market Cap $96.9M
  • Description
  • Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...
More about ANIX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.